Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury
Ischemia/reperfusion (I/R) injury is marked by the restriction and subsequent restoration of blood supply to an organ. This process can exacerbate the initial tissue damage, leading to further disorders, disability, and even death. Extracellular vesicles (EVs) are crucial in cell communication by re...
Saved in:
| Main Authors: | Weihang Zhou, Xinchi Jiang, Jianqing Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Asian Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087624000825 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances of engineered extracellular vesicles-based therapeutics strategy
by: Hiroaki Komuro, et al.
Published: (2022-12-01) -
Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application
by: Muttiah Barathan, et al.
Published: (2024-11-01) -
EMAP-II from macrophage-derived extracellular vesicles drives neutrophil extracellular traps formation via PI3K/AKT/mtROS in lung ischemia/reperfusion injury
by: Hanhong Zhuang, et al.
Published: (2025-09-01) -
Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
by: Shuang Zhao, et al.
Published: (2024-11-01) -
Adipocyte-derived small extracellular vesicles exacerbate diabetic ischemic heart injury by promoting oxidative stress and mitochondrial-mediated cardiomyocyte apoptosis
by: Lu Gan, et al.
Published: (2025-02-01)